Evolution of growth factor signaling to the TSC complex to regulate mTORC1
Science Signaling · 08.07.2025 · 18 (894)
DOI: 10.1126/scisignal.adw4165 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science Signaling, erschienen am 08.07.2025. Verfasst von Kun Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Signal Transduction, Tuberous Sclerosis Complex 2 Protein, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
The mechanistic target of rapamycin (mTOR) complex 1 (mTORC1) integrates signals from factors that both stimulate (exogenous growth factors) and are essential for (intracellular nutrients and energy) cellular growth. Activation of the protein kinase mTOR within mTORC1 results in the phosphorylation of downstream substrates that collectively stimulate biomass accumulation to drive cell growth. Many upstream signals, especially growth factors, regulate mTORC1 by inducing the phosphorylation of the tuberous sclerosis complex 2 (TSC2) subunit of the TSC protein complex, a conserved brake on mTORC1 activation and its promotion of cell growth. Cryo–electron microscopy studies of the TSC protein complex have revealed that this phosphoregulation of TSC2 occurs almost exclusively on residues in loops that are outside of the evolutionarily conserved core structural elements and that did not resolve in these structures. These phosphorylation-rich unstructured loops evolved with metazoans, suggesting that the regulation of mTORC1 by diverse growth factors likely evolved with the emergence of complex body plans and diverse cell types to coordinate cell growth and metabolism within and across distinct tissues. Unlike the core structure of TSC2, these loops lack disease-associated missense mutations. These features suggest that the regulatory loops on TSC2 are more amenable to evolutionary changes that enable diverse signals to converge on the TSC protein complex to regulate mTORC1.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
- Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
ORCID-Profile: Kun Wang, Brendan D Manning
Förderung
- NCI NIH HHS
Zitieren
APA
Wang, K., Lockwood, S. E., & Manning, B. D. (2025). Evolution of growth factor signaling to the TSC complex to regulate mTORC1. Science Signaling, 18(894). https://doi.org/10.1126/scisignal.adw4165
Vancouver
Wang K, Lockwood SE, Manning BD. Evolution of growth factor signaling to the TSC complex to regulate mTORC1. Science Signaling. 2025;18(894). doi:10.1126/scisignal.adw4165
BibTeX
@article{Wang2025,
author = {Wang, Kun and Lockwood, Sophie E and Manning, Brendan D},
title = {Evolution of growth factor signaling to the TSC complex to regulate mTORC1},
journal = {Science Signaling},
year = {2025},
volume = {18},
number = {894},
doi = {10.1126/scisignal.adw4165}
}
EUVIMED